{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:51:40Z","timestamp":1789656700543,"version":"4.0.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473156"],"award-info":[{"award-number":["82473156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202206010068"],"award-info":[{"award-number":["202206010068"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nature Science Fund of Guangdong Province","award":["2020A1515010176"],"award-info":[{"award-number":["2020A1515010176"]}]},{"name":"Shenzhen Key Medical Discipline Construction Fund","award":["SZXK039"],"award-info":[{"award-number":["SZXK039"]}]},{"name":"Shenzhen Science and Technology Plan Projects","award":["JCYJ20220530154200002"],"award-info":[{"award-number":["JCYJ20220530154200002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-00911-1","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:46:14Z","timestamp":1778067974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DNASE1L3 functions as a significant metastatic suppressor by attenuating MYH9\/\u03b2-catenin\/c-Jun\/LncRNA-KDM4A-induced E-cadherin ubiquitination degradation in nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"31","author":[{"given":"Xingyu","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beixian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"911_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan A, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394:64\u201380.","journal-title":"Lancet"},{"key":"911_CR2","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et\u00a0al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2024. https:\/\/gco.iarc.who.int\/today. Accessed 1 Nov 2024."},{"key":"911_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20042926","volume":"20","author":"R Zhang","year":"2023","unstructured":"Zhang R, He Y, Wei B, Lu Y, Zhang J, Zhang N, et al. Nasopharyngeal carcinoma burden and its attributable risk factors in China: estimates and forecasts from 1990 to 2050. Int J Environ Res Public Health. 2023;20:2926.","journal-title":"Int J Environ Res Public Health"},{"key":"911_CR4","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.7314\/APJCP.2015.16.15.6729","volume":"16","author":"Z Xu","year":"2015","unstructured":"Xu Z, Lin Z, Fang J, Wu K, Du P, Zeng Y, et al. Mortality characteristic and prediction of nasopharyngeal carcinoma in China from 1991 to 2013. Asian Pac J Cancer Prev. 2015;16:6729\u201334.","journal-title":"Asian Pac J Cancer Prev"},{"key":"911_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bjorl.2020.05.022","volume":"88","author":"N Toumi","year":"2022","unstructured":"Toumi N, Ennouri S, Charfeddine I, Daoud J, Khanfir A. Prognostic factors in metastatic nasopharyngeal carcinoma. Braz J Otorhinolaryngol. 2022;88:212\u20139.","journal-title":"Braz J Otorhinolaryngol"},{"key":"911_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.oraloncology.2012.02.017","volume":"48","author":"AWM Lee","year":"2012","unstructured":"Lee AWM, Fee WE, Ng WT, Chan LK. Nasopharyngeal carcinoma: salvage of local recurrence. Oral Oncol. 2012;48:768\u201374.","journal-title":"Oral Oncol"},{"key":"911_CR7","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1158\/1055-9965.EPI-20-1702","volume":"30","author":"ET Chang","year":"2021","unstructured":"Chang ET, Ye W, Zeng Y, Adami H. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2021;30:1035\u201347.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"911_CR8","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.3390\/curroncol29090475","volume":"29","author":"X Liu","year":"2022","unstructured":"Liu X, Deng Y, Huang Y, Ye J, Xie S, He Q, et al. Nasopharyngeal carcinoma progression: accumulating genomic instability and persistent Epstein\u2013Barr virus infection. Curr Oncol. 2022;29:6035\u201352.","journal-title":"Curr Oncol"},{"key":"911_CR9","first-page":"417","volume":"32","author":"HQ Li","year":"2007","unstructured":"Li HQ, Zhu YM, Chen JB, Tan GL. Genomic instability in nasopharyngeal carcinoma. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007;32:417\u201321.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"911_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.oraloncology.2007.10.001","volume":"44","author":"M Trimeche","year":"2008","unstructured":"Trimeche M, Braham H, Ziadi S, Amara K, Hachana M, Korbi S. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease. Oral Oncol. 2008;44:775\u201383.","journal-title":"Oral Oncol"},{"key":"911_CR11","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1158\/0008-5472.CAN-03-3253","volume":"64","author":"W Xiong","year":"2004","unstructured":"Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL, et\u00a0al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res. 2004;64:1972\u20134.","journal-title":"Cancer Res"},{"key":"911_CR12","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1093\/hmg\/ddr191","volume":"20","author":"K Tse","year":"2011","unstructured":"Tse K, Su W, Yang M, Cheng H, Tsang N, Chang K, et\u00a0al. A gender-specific association of CNV at 6p21.3 with NPC susceptibility. Hum Mol Genet. 2011;20:2889\u201396.","journal-title":"Hum Mol Genet"},{"key":"911_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/sj.ejhg.5201951","volume":"16","author":"LF Hu","year":"2008","unstructured":"Hu LF, Qiu QH, Fu SM, Sun D, Magnusson K, He B, et\u00a0al. A genome-wide scan suggests a susceptibility locus on 5p 13 for nasopharyngeal carcinoma. Eur J Hum Genet. 2008;16:343\u20139.","journal-title":"Eur J Hum Genet"},{"key":"911_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080223","volume":"8","author":"R Mizuta","year":"2013","unstructured":"Mizuta R, Araki S, Furukawa M, Furukawa Y, Ebara S, Shiokawa D, et\u00a0al. DNase gamma is the effector endonuclease for internucleosomal DNA fragmentation in necrosis. PLoS ONE. 2013;8:e80223.","journal-title":"PLoS ONE"},{"key":"911_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1292\/jvms.19-0499","volume":"82","author":"S Takada","year":"2020","unstructured":"Takada S, Watanabe T, Mizuta R. DNase gamma-dependent DNA fragmentation causes karyolysis in necrotic hepatocyte. J Vet Med Sci. 2020;82:23\u20136.","journal-title":"J Vet Med Sci"},{"key":"911_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1742-4658.2008.06849.x","volume":"276","author":"M Napirei","year":"2009","unstructured":"Napirei M, Ludwig S, Mezrhab J, Klockl T, Mannherz HG. Murine serum nucleases\u2013contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3). FEBS J. 2009;276:1059\u201373.","journal-title":"FEBS J"},{"key":"911_CR17","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1074\/jbc.M112.423061","volume":"288","author":"Y Errami","year":"2013","unstructured":"Errami Y, Naura AS, Kim H, Ju J, Suzuki Y, El-Bahrawy AH, et al. Apoptotic DNA fragmentation may be a cooperative activity between caspase-activated deoxyribonuclease and the poly(ADP-ribose) polymerase-regulated DNAS1L3, an endoplasmic reticulum-localized endonuclease that translocates to the nucleus during apoptosis. J Biol Chem. 2013;288:3460\u20138.","journal-title":"J Biol Chem"},{"key":"911_CR18","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.ccell.2025.07.014","volume":"43","author":"D Chen","year":"2025","unstructured":"Chen D, Jin Z, Chu H, Wu Y, Bian Y, Yuan T, et al. DNASE1L3-expressing dendritic cells promote CD8(+) T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps. Cancer Cell. 2025;43:1758\u201375.","journal-title":"Cancer Cell"},{"key":"911_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","volume":"166","author":"V Sisirak","year":"2016","unstructured":"Sisirak V, Sally B, D\u2019Agati V, Martinez-Ortiz W, Ozcakar ZB, David J, et al. Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell. 2016;166:88\u2013101.","journal-title":"Cell"},{"key":"911_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead050","author":"B Skaug","year":"2023","unstructured":"Skaug B, Guo X, Li YJ, Charles J, Pham KT, Couturier J, et al. Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant. Rheumatology. 2023;62:3197\u2013204.","journal-title":"Rheumatology"},{"key":"911_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10238-016-0448-8","volume":"17","author":"Q Zhao","year":"2017","unstructured":"Zhao Q, Yang C, Wang J, Li Y, Yang P. Serum level of DNase1l3 in patients with dermatomyositis\/polymyositis, systemic lupus erythematosus and rheumatoid arthritis, and its association with disease activity. Clin Exp Med. 2017;17:459\u201365.","journal-title":"Clin Exp Med"},{"key":"911_CR22","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2147\/OTT.S294332","volume":"14","author":"Z Deng","year":"2021","unstructured":"Deng Z, Xiao M, Du D, Luo N, Liu D, Liu T, et\u00a0al. DNASE1L3 as a prognostic biomarker associated with immune cell infiltration in cancer. Oncotargets Ther. 2021;14:2003\u201317.","journal-title":"Oncotargets Ther"},{"key":"911_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep44997","volume":"7","author":"S Bhalla","year":"2017","unstructured":"Bhalla S, Chaudhary K, Kumar R, Sehgal M, Kaur H, Sharma S, et\u00a0al. Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer. Sci Rep. 2017;7:44997.","journal-title":"Sci Rep"},{"key":"911_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.699242","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, Ding J, Huang W, Sun L, Chen J, Liu Y, et\u00a0al. DNASE1L3 as a novel diagnostic and prognostic biomarker for lung adenocarcinoma based on data mining. Front Genet. 2021;12:699242.","journal-title":"Front Genet"},{"key":"911_CR25","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.18632\/aging.102675","volume":"12","author":"S Wang","year":"2020","unstructured":"Wang S, Ma H, Li X, Mo X, Zhang H, Yang L, et al. DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection. Aging Albany NY. 2020;12:1171\u201385.","journal-title":"Aging Albany NY"},{"key":"911_CR26","doi-asserted-by":"publisher","first-page":"16513","DOI":"10.18632\/aging.203173","volume":"13","author":"J Liu","year":"2021","unstructured":"Liu J, Yi J, Zhang Z, Cao D, Li L, Yao Y. Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer. Aging (Albany NY). 2021;13:16513\u201326.","journal-title":"Aging (Albany NY)"},{"key":"911_CR27","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2023.2615","volume":"18","author":"Q Bai","year":"2023","unstructured":"Bai Q, He X, Hu T. Pan-cancer analysis of the deoxyribonuclease gene family. Mol Clin Oncol. 2023;18:19.","journal-title":"Mol Clin Oncol"},{"key":"911_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13273","volume":"55","author":"B Li","year":"2022","unstructured":"Li B, Ge YZ, Yan WW, Gong B, Cao K, Zhao R, et\u00a0al. DNASE1L3 inhibits proliferation, invasion and metastasis of hepatocellular carcinoma by interacting with beta-catenin to promote its ubiquitin degradation pathway. Cell Proliferat. 2022;55:e13273.","journal-title":"Cell Proliferat"},{"key":"911_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1386","volume":"11","author":"N Li","year":"2022","unstructured":"Li N, Zheng X, Chen M, Huang L, Chen L, Huo R, et\u00a0al. Deficient DNASE1L3 facilitates neutrophil extracellular traps-induced invasion via cyclic GMP-AMP synthase and the non-canonical NF-kappaB pathway in diabetic hepatocellular carcinoma. Clin Transl Immunol. 2022;11:e1386.","journal-title":"Clin Transl Immunol"},{"key":"911_CR30","doi-asserted-by":"publisher","first-page":"9874","DOI":"10.18632\/aging.202740","volume":"13","author":"D Guo","year":"2021","unstructured":"Guo D, Ma D, Liu P, Lan J, Liu Z, Liu Q. DNASE1L3 arrests tumor angiogenesis by impairing the senescence-associated secretory phenotype in response to stress. Aging (Albany NY). 2021;13:9874\u201399.","journal-title":"Aging (Albany NY)"},{"key":"911_CR31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4149\/neo_2021_201010N1069","volume":"68","author":"QY Chen","year":"2021","unstructured":"Chen QY, Li L, Suo DQ. DNase1L3 suppresses hepatocellular carcinoma growth via inhibiting complement autocrine effect. Neoplasma. 2021;68:683\u201391.","journal-title":"Neoplasma"},{"key":"911_CR32","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s13402-022-00709-1","volume":"45","author":"J Sun","year":"2022","unstructured":"Sun J, Wang X, Shen Q, Wang M, Chen S, Zhang X, et al. DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2. Cell Oncol. 2022;45:1187\u2013202.","journal-title":"Cell Oncol"},{"key":"911_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.7150\/ijbs.57919","volume":"18","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Yang K, Liu P, Ma D, Lei P, Liu Q. Deoxyribonuclease 1-like 3 inhibits hepatocellular carcinoma progression by inducing apoptosis and reprogramming glucose metabolism. Int J Biol Sci. 2022;18:82\u201395.","journal-title":"Int J Biol Sci"},{"key":"911_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101534","volume":"12","author":"Z Shi","year":"2025","unstructured":"Shi Z, Jin S, Liu X, Jiang M, Fang Y, Khadaroo PA, et\u00a0al. The epigenetic regulatory network of long noncoding RNAs in hepatocellular carcinoma. Genes Dis. 2025;12:101534.","journal-title":"Genes Dis"},{"key":"911_CR35","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1172\/JCI84421","volume":"126","author":"JR Evans","year":"2016","unstructured":"Evans JR, Feng FY, Chinnaiyan AM. The bright side of dark matter: lncRNAs in cancer. J Clin Invest. 2016;126:2775\u201382.","journal-title":"J Clin Invest"},{"key":"911_CR36","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1158\/0008-5472.CAN-19-0799","volume":"79","author":"ZQ Zheng","year":"2019","unstructured":"Zheng ZQ, Li ZX, Zhou GQ, Lin L, Zhang LL, Lv JW, et al. Long noncoding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p\/miR-1275 and upregulate ITGB3. Cancer Res. 2019;79:4612\u201326.","journal-title":"Cancer Res"},{"key":"911_CR37","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1158\/0008-5472.CAN-19-3626","volume":"80","author":"ZQ Zheng","year":"2020","unstructured":"Zheng ZQ, Li ZX, Guan JL, Liu X, Li JY, Chen Y, et\u00a0al. Long noncoding RNA TINCR-mediated regulation of Acetyl-CoA metabolism promotes nasopharyngeal carcinoma progression and chemoresistance. Cancer Res. 2020;80:5174\u201388.","journal-title":"Cancer Res"},{"key":"911_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02349-z","volume":"24","author":"B Gong","year":"2025","unstructured":"Gong B, Liu Y, Yan W, Cheng C, Yang H, Huang J, et\u00a0al. NAP1L1 degradation by FBXW7 reduces the deubiquitination of HDGF-p62 signaling to stimulate autophagy and induce primary cisplatin chemosensitivity in nasopharyngeal carcinoma. Mol Cancer. 2025;24:152.","journal-title":"Mol Cancer"},{"key":"911_CR39","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/mc.22604","volume":"56","author":"Z Luo","year":"2017","unstructured":"Luo Z, Li Y, Zuo M, Liu C, Tian W, Yan D, et\u00a0al. Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers. Mol Carcinogen. 2017;56:1438\u201348.","journal-title":"Mol Carcinogen"},{"key":"911_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2022.01.025","volume":"531","author":"R Hou","year":"2022","unstructured":"Hou R, Liu X, Yang H, Deng S, Cheng C, Liu J, et al. Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression. Cancer Lett. 2022;531:57\u201370.","journal-title":"Cancer Lett"},{"key":"911_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13046-022-02560-6","volume":"42","author":"X Tao","year":"2023","unstructured":"Tao X, Li Y, Fan S, Wu L, Xin J, Su Y, et\u00a0al. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275\/PROCA1\/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma. J Exp Clin Canc Res. 2023;42:12.","journal-title":"J Exp Clin Canc Res"},{"key":"911_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/onc.2016.201","volume":"36","author":"Y Zhen","year":"2017","unstructured":"Zhen Y, Fang W, Zhao M, Luo R, Liu Y, Fu Q, et al. miR-374a-CCND1-pPI3K\/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin. Oncogene. 2017;36:275\u201385.","journal-title":"Oncogene"},{"key":"911_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/br.2015.494","volume":"3","author":"BO Sun","year":"2015","unstructured":"Sun BO, Fang Y, Li Z, Chen Z, Xiang J. Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression. Biomed Rep. 2015;3:603\u201310.","journal-title":"Biomed Rep"},{"key":"911_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cells9041040","volume":"9","author":"M Sommariva","year":"2020","unstructured":"Sommariva M, Gagliano N. E-cadherin in pancreatic ductal adenocarcinoma: a multifaceted actor during EMT. Cells. 2020;9:1040.","journal-title":"Cells"},{"key":"911_CR45","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2119\/molmed.2016.00041","volume":"22","author":"A Korol","year":"2016","unstructured":"Korol A, Taiyab A, West-Mays JA. RhoA\/ROCK signaling regulates TGFbeta-induced epithelial-mesenchymal transition of lens epithelial cells through MRTF-A. Mol Med. 2016;22:713\u201323.","journal-title":"Mol Med"},{"key":"911_CR46","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1083\/jcb.200708174","volume":"179","author":"T Morita","year":"2007","unstructured":"Morita T, Mayanagi T, Sobue K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J Cell Biol. 2007;179:1027\u201342.","journal-title":"J Cell Biol"},{"key":"911_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41392-020-0111-4","volume":"5","author":"X Lin","year":"2020","unstructured":"Lin X, Li AM, Li YH, Luo RC, Zou YJ, Liu YY, et\u00a0al. Silencing MYH9 blocks HBx-induced GSK3beta ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma. Signal Transduct Tar. 2020;5:13.","journal-title":"Signal Transduct Tar"},{"key":"911_CR48","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/s41401-022-00890-x","volume":"43","author":"JH Liu","year":"2022","unstructured":"Liu JH, Yang HL, Deng ST, Hu Z, Chen WF, Yan WW, et al. The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma. Acta Pharmacol Sin. 2022;43:2687\u201395.","journal-title":"Acta Pharmacol Sin"},{"key":"911_CR49","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.7150\/ijbs.67476","volume":"18","author":"R Hou","year":"2022","unstructured":"Hou R, Li Y, Luo X, Zhang W, Yang H, Zhang Y. ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating beta-catenin\/c-Jun\/MYH9\/USP7\/c-Myc axis. Int J Biol Sci. 2022;18:2553\u201367.","journal-title":"Int J Biol Sci"},{"key":"911_CR50","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ebiom.2019.08.040","volume":"48","author":"Y Liu","year":"2019","unstructured":"Liu Y, Jiang Q, Liu X, Lin X, Tang Z, Liu C, et\u00a0al. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA\/glycogen synthase 3beta\/beta-catenin signaling pathway. EBioMedicine. 2019;48:386\u2013404.","journal-title":"EBioMedicine"},{"key":"911_CR51","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41401-024-01335-3","volume":"45","author":"JN Zhang","year":"2024","unstructured":"Zhang JN, Zhang Z, Huang ZL, Guo Q, Wu ZQ, Ke C, et al. Isotoosendanin inhibits triple-negative breast cancer metastasis by reducing mitochondrial fission and lamellipodia formation regulated by the Smad2\/3-GOT2-MYH9 signaling axis. Acta Pharmacol Sin. 2024;45:2672\u201383.","journal-title":"Acta Pharmacol Sin"},{"key":"911_CR52","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452\u201363.","journal-title":"Cancer Cell"},{"key":"911_CR53","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965\u201381.","journal-title":"Cancer Res"},{"key":"911_CR54","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.2147\/CMAR.S305544","volume":"13","author":"Q Wu","year":"2021","unstructured":"Wu Q, Zhao Y, Shi R, Wang T. LncRNA SNHG16 facilitates nasopharyngeal carcinoma progression by acting as ceRNA to sponge miR-520a-3p and upregulate MAPK1 expression. Cancer Manag Res. 2021;13:4103\u201314.","journal-title":"Cancer Manag Res"},{"key":"911_CR55","first-page":"124","volume":"199","author":"W Zhang","year":"2023","unstructured":"Zhang W, Zhou X, Tang Z, Fu L, Zou S, Tang S. Knockdown of lncRNA SNHG16 attenuates the proliferation and radioresistance of nasopharyngeal carcinoma cells by mediating miR-31-5p\/SFN axis. Radiat Res. 2023;199:124\u201331.","journal-title":"Radiat Res"},{"key":"911_CR56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12010-023-04558-y","volume":"196","author":"W Hou","year":"2023","unstructured":"Hou W, Xu L, Su T, Wu Y, Liu Y, Wei Y. Hypoxia induces tumor-derived exosome SNHG16 to mediate nasopharyngeal carcinoma progression through the miR-23b-5p\/MCM6 pathway. Appl Biochem Biotech. 2023;196:275\u201395.","journal-title":"Appl Biochem Biotech"},{"key":"911_CR57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/hep.29798","volume":"68","author":"M Lu","year":"2018","unstructured":"Lu M, Wu J, Hao ZW, Shang YK, Xu J, Nan G, et\u00a0al. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress. Hepatology. 2018;68:317\u201332.","journal-title":"Hepatology"},{"key":"911_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07081-z","volume":"20","author":"PA Bissey","year":"2020","unstructured":"Bissey PA, Teng M, Law JH, Shi W, Bruce JP, Petit V, et al. Mir-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma. BMC Cancer. 2020;20:597.","journal-title":"BMC Cancer"},{"key":"911_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cels.2019.07.003","volume":"9","author":"Y Suhail","year":"2019","unstructured":"Suhail Y, Cain MP, Vanaja K, Kurywchak PA, Levchenko A, Kalluri R. Systems biology of cancer metastasis. Cell Syst. 2019;9:109\u201327.","journal-title":"Cell Syst"},{"key":"911_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00607-4","volume":"29","author":"Y Wu","year":"2024","unstructured":"Wu Y, Jia Q, Tang Q, Chen L, Deng H, He Y, et al. A specific super-enhancer actuated by berberine regulates EGFR-mediated RAS-RAF1-MEK1\/2-ERK1\/2 pathway to induce nasopharyngeal carcinoma autophagy. Cell Mol Biol Lett. 2024;29:92.","journal-title":"Cell Mol Biol Lett"},{"key":"911_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12003","volume":"10","author":"F Li","year":"2020","unstructured":"Li F, Zhao X, Sun R, Ou J, Huang J, Yang N, et al. EGFR-rich extracellular vesicles derived from highly metastatic nasopharyngeal carcinoma cells accelerate tumour metastasis through PI3K\/AKT pathway-suppressed ROS. J Extracell Vesicles. 2020;10:e12003.","journal-title":"J Extracell Vesicles"},{"key":"911_CR62","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/s41418-023-01171-8","volume":"30","author":"P Wu","year":"2023","unstructured":"Wu P, Hou X, Peng M, Deng X, Yan Q, Fan C, et al. Circular RNA circRILPL1 promotes nasopharyngeal carcinoma malignant progression by activating the Hippo-YAP signaling pathway. Cell Death Differ. 2023;30:1679\u201394.","journal-title":"Cell Death Differ"},{"key":"911_CR63","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1038\/s41388-019-0806-6","volume":"38","author":"P Zhou","year":"2019","unstructured":"Zhou P, Li Y, Li B, Zhang M, Liu Y, Yao Y. NMIIA promotes tumor growth and metastasis by activating the Wnt\/beta-catenin signaling pathway and EMT in pancreatic cancer. Oncogene. 2019;38:5500\u201315.","journal-title":"Oncogene"},{"key":"911_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00583-9","volume":"29","author":"Y Lin","year":"2024","unstructured":"Lin Y, Chen X, Lin L, Xu B, Zhu X, Lin X. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9\/GSK3\u03b2\/\u03b2-catenin signaling. Cell Mol Biol Lett. 2024;29:63.","journal-title":"Cell Mol Biol Lett"},{"key":"911_CR65","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.7150\/jca.47506","volume":"12","author":"D Xiong","year":"2021","unstructured":"Xiong D, Chen D, Liu D, Wu W, Dou X, Ji X, et\u00a0al. The overexpression of NMHC IIA promoted invasion and metastasis of nasopharyngeal carcinoma cells. J Cancer. 2021;12:4218\u201328.","journal-title":"J Cancer"},{"key":"911_CR66","doi-asserted-by":"publisher","first-page":"18228","DOI":"10.1074\/jbc.M112.349480","volume":"288","author":"ME de Araujo","year":"2013","unstructured":"de Araujo ME, Stasyk T, Taub N, Ebner HL, Furst B, Filipek P, et\u00a0al. Stability of the endosomal scaffold protein LAMTOR3 depends on heterodimer assembly and proteasomal degradation. J Biol Chem. 2013;288:18228\u201342.","journal-title":"J Biol Chem"},{"key":"911_CR67","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10308","author":"JD Mancias","year":"2015","unstructured":"Mancias JD, Pontano VL, Nissim S, Biancur DE, Kim AJ, Wang X, et al. Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. Elife. 2015;4:e10308.","journal-title":"Elife"},{"key":"911_CR68","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.parkreldis.2015.01.005","volume":"21","author":"MR Cornejo-Olivas","year":"2015","unstructured":"Cornejo-Olivas MR, Torres L, Mata IF, Mazzetti P, Rivas D, Cosentino C, et\u00a0al. A Peruvian family with a novel PARK2 mutation: clinical and pathological characteristics. Parkinsonism Relat Disord. 2015;21:444\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"911_CR69","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1158\/0008-5472.CAN-14-1433","volume":"75","author":"DC Lin","year":"2015","unstructured":"Lin DC, Xu L, Chen Y, Yan H, Hazawa M, Doan N, et\u00a0al. Genomic and functional analysis of the E3 ligase PARK2 in glioma. Cancer Res. 2015;75:1815\u201327.","journal-title":"Cancer Res"},{"key":"911_CR70","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.7150\/thno.46078","volume":"10","author":"X Zhou","year":"2020","unstructured":"Zhou X, Li Y, Wang W, Wang S, Hou J, Zhang A, et\u00a0al. Regulation of Hippo\/YAP signaling and esophageal squamous carcinoma progression by an E3 ubiquitin ligase PARK2. Theranostics. 2020;10:9443\u201357.","journal-title":"Theranostics"},{"key":"911_CR71","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s00018-016-2255-5","volume":"73","author":"GL Grice","year":"2016","unstructured":"Grice GL, Nathan JA. The recognition of ubiquitinated proteins by the proteasome. Cell Mol Life Sci. 2016;73:3497\u2013506.","journal-title":"Cell Mol Life Sci"},{"key":"911_CR72","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020422","volume":"99","author":"B Deng","year":"2020","unstructured":"Deng B, Yang M, Wang M, Liu Z. Development and validation of 9-long non-coding RNA signature to predicting survival in hepatocellular carcinoma. Medicine (Baltimore). 2020;99:e20422.","journal-title":"Medicine (Baltimore)"},{"key":"911_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.779269","volume":"10","author":"T Wang","year":"2022","unstructured":"Wang T, Yang Y, Sun T, Qiu H, Wang J, Ding C, et\u00a0al. The pyroptosis-related long noncoding RNA signature predicts prognosis and indicates immunotherapeutic efficiency in hepatocellular carcinoma. Front Cell Dev Biol. 2022;10:779269.","journal-title":"Front Cell Dev Biol"},{"key":"911_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1153353","volume":"13","author":"W Yuan","year":"2023","unstructured":"Yuan W, Xiao JH, Zhang JS, Mao BL, Wang PZ, Wang BL. Identification of a cuproptosis and copper metabolism gene-related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma. Front Oncol. 2023;13:1153353.","journal-title":"Front Oncol"},{"key":"911_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1171878","volume":"13","author":"L Zhao","year":"2023","unstructured":"Zhao L, You Z, Bai Z, Xie J. Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer. Front Oncol. 2023;13:1171878.","journal-title":"Front Oncol"},{"key":"911_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-023-00607-0","author":"HM Shen","year":"2023","unstructured":"Shen HM, Zhang D, Xiao P, Qu B, Sun YF. E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA. Cancer Gene Ther. 2023;30:1007\u201317.","journal-title":"Cancer Gene Ther"},{"key":"911_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04449-2","volume":"12","author":"T Chen","year":"2021","unstructured":"Chen T, Liu R, Niu Y, Mo H, Wang H, Lu Y. HIF-1alpha-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p\/KPNA2\/AKT pathway. Cell Death Dis. 2021;12:1152.","journal-title":"Cell Death Dis"},{"key":"911_CR78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1615\/CritRevEukaryotGeneExpr.2024051414","volume":"34","author":"W Cao","year":"2024","unstructured":"Cao W, Ren Y, Liu Y, Cao G, Chen Z, Wang F. KDM4A-AS1 promotes cell proliferation, migration, and invasion via the miR-4306\/STX6 axis in hepatocellular carcinoma. Crit Rev Eukaryot Gene Expr. 2024;34:55\u201368.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"911_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13424","author":"B Zhou","year":"2023","unstructured":"Zhou B, Wu Y, Cheng P, Wu C. Long noncoding RNAs with peptide-encoding potential identified in esophageal squamous cell carcinoma: KDM4A-AS1-encoded peptide weakens cancer cell viability and migratory capacity. Mol Oncol. 2023;7:1419\u201336.","journal-title":"Mol Oncol"},{"key":"911_CR80","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a002998","volume":"1","author":"M Cavey","year":"2009","unstructured":"Cavey M, Lecuit T. Molecular bases of cell-cell junctions stability and dynamics. Cold Spring Harb Perspect Biol. 2009;1:a2998.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"911_CR81","doi-asserted-by":"publisher","first-page":"13753","DOI":"10.1074\/jbc.M710034200","volume":"283","author":"K Minami","year":"2008","unstructured":"Minami K, Okano H, Okumachi A, Seino S. Role of cadherin-mediated cell-cell adhesion in pancreatic exocrine-to-endocrine transdifferentiation. J Biol Chem. 2008;283:13753\u201361.","journal-title":"J Biol Chem"},{"key":"911_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101691","volume":"13","author":"S Wang","year":"2025","unstructured":"Wang S, Guo M, Xu L, Xue J, Chen S, Xu K, et\u00a0al. NRG4 suppresses breast cancer metastasis via ERBB4-YAP1-mediated down-regulation of MMPs. Genes Dis. 2025;13:101691.","journal-title":"Genes Dis"},{"key":"911_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-025-00693-y","volume":"30","author":"JJ Escuder-Rodr\u00edguez","year":"2025","unstructured":"Escuder-Rodr\u00edguez JJ, Rodr\u00edguez-Alonso A, Jove L, Quiroga M, Alfons\u00edn G, Figueroa A. Beyond destruction: emerging roles of the E3 ubiquitin ligase Hakai. Cell Mol Biol Lett. 2025;30:9.","journal-title":"Cell Mol Biol Lett"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00911-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:01:29Z","timestamp":1783958489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00911-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["911"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00911-1","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was granted approval by the ethics committee of Nanfang Hospital of Southern Medical University (approval no. NFEC-2017-165; approved date 23 October 2017), and informed consent was obtained from each participant. This study involving human tissue was conducted in accordance with the Declaration of Helsinki (revised 2013). All animal experiments were approved by the Experimental Animal Welfare and Ethics Committee of the Integrated Hospital of Traditional Chinese Medicine, Southern Medical University (approval no. L2020-042; approved date 21 March 2020), and conducted in compliance with the International Council for Laboratory Animal Science (ICLAS) guidelines and acts under the principles and standards established by the ICLAS Ethics and Animal Welfare Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to submit the article for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}